Each episode of AJP Audio brings you an in-depth look at one of the articles featured in that month’s issue of The American Journal of Psychiatry, the official journal of the American Psychiatric Association. Wide-ranging interviews with article authors cover the background, rationale, main findings, and future implications of the research. This podcast is subject to the Terms of Use at ww.psychiatry.org. The views and opinions expressed in this podcast are those of the individual speakers only and do not necessarily represent the views of the American Psychiatric Association, its officers, trustees, or members. The content of this podcast is provided for general informational purposes only and is not intended as, and shall not be understood or construed as, medical or any other type of professional advice nor does it represent any statement of the standard of care. We strongly recommend that any listener follow the advice of physicians directly involved in their care and contact their local emergency response number for any medical emergency. The information within this podcast is provided as-is and is not guaranteed to be correct, complete, or accurate.
https://ajp.psychiatryonline.org/audio
episode 125: March 2018 Highlights
This month, Philip McGuire, F.R.C.Psych., F.Med.Sci., of King’s College London, talks about his article investigating how cannabidiol, a compound in marijuana, can be used to treat schizophrenia. Executive Editor Michael Roy discusses new research on the relationship between age-related hearing loss and cognitive decline, the change from mild cognitive impairment to Alzheimer’s dementia, and computer-assisted cognitive-behavioral therapy (CBT) versus standard CBT. The clinical case conference looks at the value of exercise in early psychosis
Articles may be viewed online at ajp.psychiatryonline.org. Also visit the online edition of this month’s Journal to watch a video of Deputy Editor Daniel S. Pine, M.D., present highlights from the issue (ajp.psychiatryonline.org/toc/ajp/175/3).